Diabetes Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Diabetes stocks.

Diabetes Stocks Recent News

Date Stock Title
Oct 4 BMY Bristol-Myers trades in the green for seventh straight session
Oct 4 BMY Q3 pharma and biotech layoffs in charts: More than 1000 each in July and August
Oct 4 BMY UMB to refile $6.4B lawsuit against Bristol-Myers by end of next week - report
Oct 4 MNKD Exploring High Growth Tech Stocks In The United States October 2024
Oct 4 MNKD MannKind (MNKD) Just Overtook the 20-Day Moving Average
Oct 4 BMY Bristol Myers' $10B Cancer Drug Opdivo Scores Expanded Use FDA Approval For Lung Cancer In Pre And Post-Surgery Setting
Oct 4 BMY Opdivo gets ‘perioperative’ approval; pharmas cut jobs in New Jersey, Ireland
Oct 4 BMY BMS receives FDA approval for Opdivo to treat NSCLC
Oct 3 BMY U.S. Food and Drug Administration Approves Perioperative Treatment of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Single-Agent Opdivo for Resectable Non-Small Cell Lung Cancer (NSCLC)
Oct 3 BMY Bristol-Myers Squibb's Profits, Stock Price Kick Into High Gear
Oct 3 BMY Bristol-Myers wins FDA nod for Opdivo lung cancer indication
Oct 3 BMY U.S. tweaks 2025 Medicare price negotiation process
Oct 3 MNKD MannKind Leverages Tyvaso DPI Strength In Pulmonary Market Expansion
Oct 3 BMY 2 Passive Income Stocks to Load Up On in October
Oct 2 BMY STTK Discontinues Cancer Program, Plans Workforce Cut, Stock Falls
Oct 2 ALKS Alkermes (NASDAQ:ALKS) shareholder returns have been favorable, earning 62% in 5 years
Oct 2 OCS Oculis Announces Appointment of Daniel S. Char as Chief Legal Officer
Oct 1 BMY PRME Stock Rises 11.8% on Collaboration With Bristol Myers
Oct 1 BMY A schizophrenia win for BMS’ Cobenfy, but challenges lie ahead
Oct 1 CORT Wall Street Analysts Think Corcept (CORT) Could Surge 41.31%: Read This Before Placing a Bet
Diabetes

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

Browse All Tags